当前位置： SCI文献检索 > ANESTHESIOLOGY期刊下所有文献 > Continuous interscalene analgesia with ropivacaine 2 mg/ml after major shoulder surgery.

Continuous interscalene analgesia with ropivacaine 2 mg/ml after major shoulder surgery.

Abstract：

BACKGROUND:In this open, randomized study, the pharmacokinetics, clinical efficacy, and safety of a 48-h continuous interscalene infusion of 2 mg/ml ropivacaine for postoperative pain relief were investigated in patients undergoing open major shoulder surgery. METHODS:An initial interscalene block with 30 ml ropivacaine, 7.5 mg/ml (225 mg), was performed. After completion of interscalene block, all patients (n = 24) received general anesthesia, and 6 h after interscalene block, a 48-h continuous interscalene infusion of 12 or 18 mg/h using 2 mg/ml ropivacaine was started. Total and unbound plasma concentrations of ropivacaine and 2.6-pipecoloxylidide (PPX; a major active metabolite) were determined during and up to 6 h after the interscalene infusion. Postoperative pain at rest was assessed by a visual analog scale. Supplementary analgesics and adverse events were recorded. RESULTS:Plasma concentrations of total and unbound ropivacaine were proportional to the total dose. At the end of the interscalene infusion of 9 ml/h, the mean +/- SD plasma concentrations of total and unbound ropivacaine were 1.40 +/- 0.54 and 0.03 +/- 0.01 mg/l, respectively, and of total and unbound PPX were 0.70 +/- 0.38 and 0.30 +/- 0.20 mg/l, respectively. Plasma concentrations of unbound ropivacaine and unbound PPX, added together, remained well below threshold levels for systemic central nervous system toxicity. There were no significant differences between the groups for postoperative pain (median maximum of about 20 mm on the visual analog scale in both groups), analgesic consumption, or quality of pain relief assessed by the patient. No signs or symptoms of systemic local anesthetic toxicity were observed. CONCLUSION:A 48-h continuous interscalene infusion of 6 or 9 ml/h ropivacaine, 2 mg/ml, started 6 h after an initial interscalene block of 30 ml ropivacaine, 7.5 mg/ml, provided satisfactory postoperative pain relief after major shoulder surgery and was well tolerated. Unbound plasma concentrations of ropivacaine and PPX remained well below threshold levels for systemic central nervous toxicity.

journal_name

Anesthesiology

journal_title

Anesthesiology

authors

Ekatodramis G,Borgeat A,Huledal G,Jeppsson L,Westman L,Sjövall J

doi

10.1097/00000542-200301000-00023

subject

Has Abstract

pub_date

2003-01-01 00:00:00

pages

143-50

issue

eissn

0003-3022

issn

1528-1175

pii

00000542-200301000-00023

journal_volume

pub_type

临床试验,杂志文章,随机对照试验

在线工具

Continuous interscalene analgesia with ropivacaine 2 mg/ml after major shoulder surgery.